ScholarIQanswers from OpenAlex & ORCID
Nicolas Belmar
ResearcherPublications, citations & collaboration network
Nicolas Belmar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Nicolas Belmar have?
ScholarIQindexed works
Nicolas Belmar has 22 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Nicolas Belmar have?
ScholarIQcitation count
Nicolas Belmar has 235 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Nicolas Belmar?
ScholarIQh-index
Nicolas Belmar has an h-index of 6 in OpenAlex.
What is the i10-index of Nicolas Belmar?
ScholarIQi10-index
Nicolas Belmar has an i10-index of 3 in OpenAlex.
What is the OpenAlex record for Nicolas Belmar?
ScholarIQopenalex
The OpenAlex for Nicolas Belmar is on the source record.
What are the most-cited papers on Nicolas Belmar?
ScholarIQmost cited works
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
Johannes F.E. Mann, Peter Rossing, George L. Bakris, Nicolas Belmar, Heidrun Bosch‐Traberg, Robert S. Busch, David M. Charytan, Samy Hadjadj, Pieter Gillard, José Luis Górriz, Thomas Idorn, Linong Ji, Kenneth W. Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland E. Schmieder, Richard E. Pratley, Katherine R. Tuttle
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing, George L. Bakris, Vlado Perkovic, Richard E. Pratley, Katherine R. Tuttle, Kenneth W. Mahaffey, Thomas Idorn, Nicolas Belmar, Heidrun Bosch‐Traberg, Søren Rasmussen, Robert S. Busch, Roland E. Schmieder, Pieter Gillard, Johannes F. E. Mann, FLOW Investigator Group, Andrea Da Porto, A. Oviedo, Alicia Elbert, Elizabeth Gelersztein, Alejandro Chertkoff, A. Wassermann, Miguel Ángel Quevedo, R. J. MacIsaac, S Roger, Richard Phoon, Kerr Pg, Andrew E. Ajani, Shaobo Tan, David Colquhoun, Amanda Mather, P. Gillard, Christophe De Block, Corinne Debroye, Francis Duyck, J.M. Krzesinski, Bruno Lapauw, V. Preumont, C. Vercammen, Zdravko Kamenov, Roza Bobeva, G. Levterov, S. Gerilovska, N. Yabrudi, Bilyana Stoyanovska-Elencheva, Z. Nikitov, Daniel Franco, Gustavo Akerman Augusto, Jean‐Pierre Salles, Luís Henrique Santos Canani, Márcio Krakauer, Maria Cerqueira, Miguel C. Riella, Hitasha Bajaj, Rolf Schlößer, Buki Ajala, Neeru P Aggarwal, R Dumas, Daniel J. O’Keefe, Sean Peterson, George Tsoukas, Chetna Tailor, Richard Tytus, Ronald Akhras, Hasnain Khandwala, Oren Steen, Diane Carbonneau, Jihoon Cha, Ann Steele, G. HOWARD BAILEY, Joseph Berlingieri, Peter Dzongowski, David Z.I. Cherney, Thomas G. Elliott, C. J. Kovacs, Pavel Hamet, BRUCE PERKINS, Karthik Tennankore, Anil Kumar Gupta, Linong Ji, Yan Li, Gongsheng Yuan, Xinzhong Dong, B. Cariou, S. Clavel, Loı̈c Le Marchand, Yves Reznik, Philippe Moulin, E. Legrand, I. Benoit Tricaud, Pierre Gourdy, Philippe Zaoui, Anne Monier, Isabelle Kazes, Dominik Dahl, Melissa M. Esser, Thilo Krüger, Ludger Rose, R. Schmieder, Alexander Segner, Young Hee Lee-Barkey
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease
David Z.I. Cherney, Nicolas Belmar, Petter Bjornstad, Milenta Mariam Chacko, Thomas P. Gunnarsson, Jeffrey B. Hodgin, Matthias Kretzler, Menno Pruijm, Philip Andreas Schytz, Katherine R. Tuttle
Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
Stephen C. Bain, Nicolas Belmar, Søren T. Hoff, Mansoor Husain, Søren Rasmussen, Tina Vilsbøll, Mark C. Petrie
REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide
Menno Pruijm, Nicolas Belmar, Petter Bjornstad, David Z.I. Cherney, Vivek Das, Thomas P. Gunnarsson, Jeffrey B. Hodgin, Philip Andreas Schytz, Katherine R. Tuttle, Matthias Kretzler